Cargando…

CSF nonphosphorylated Tau as a biomarker for the discrimination of AD from CJD

Creutzfeldt–Jakob disease and Alzheimer's disease are characterized by the presence of elevated total‐Tau cerebrospinal fluid concentrations while the presence of hyperphosphorylated Tau forms in the cerebrospinal fluid is rather a hallmark of Alzheimer's disease. Here we aimed to investig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ermann, Natalia, Lewczuk, Piotr, Schmitz, Matthias, Lange, Peter, Knipper, Tobias, Goebel, Stefan, Kornhuber, Johannes, Zerr, Inga, Llorens, Franc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Brief Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043772/ https://www.ncbi.nlm.nih.gov/pubmed/30009207 http://dx.doi.org/10.1002/acn3.584

Ejemplares similares

Progress in CSF biomarker discovery in sCJD
por: Llorens, Franc, et al.
Publicado: (2016)

Brain-derived proteins in the CSF, do they correlate with brain pathology in CJD?
por: Boesenberg-Grosse, Constanze, et al.
Publicado: (2006)

Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Show Different but Partially Overlapping Profile Compared to Vascular Dementia
por: Llorens, Franc, et al.
Publicado: (2017)

NT1-Tau Is Increased in CSF and Plasma of CJD Patients, and Correlates with Disease Progression
por: Mengel, David, et al.
Publicado: (2021)

Cerebrospinal fluid α synuclein concentrations in patients with positive AD biomarkers and extrapyramidal symptoms
por: Winkel, Izabela, et al.
Publicado: (2021)

Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease
por: Llorens, Franc, et al.
Publicado: (2017)

Application of Nonphosphorylative Metabolism as an Alternative for Utilization of Lignocellulosic Biomass
por: McClintock, Maria K., et al.
Publicado: (2017)

Imaging and CSF analyses effectively distinguish CJD from its mimics
por: Rudge, Peter, et al.
Publicado: (2018)

Doxycycline in early CJD: a double-blinded randomised phase II and observational study
por: Varges, Daniela, et al.
Publicado: (2017)

Diagnostic and prognostic value of plasma neurofilament light and total-tau in sporadic Creutzfeldt-Jakob disease
por: Zerr, Inga, et al.
Publicado: (2021)

A Specific Reduction in Aβ(1−42) vs. a Universal Loss of Aβ Peptides in CSF Differentiates Alzheimer's Disease From Meningitis and Multiple Sclerosis
por: Spitzer, Philipp, et al.
Publicado: (2018)

Cerebrospinal fluid neurogranin as a new player in prion disease diagnosis and prognosis
por: Villar-Piqué, Anna, et al.
Publicado: (2019)

Combined Analysis of CSF Tau, Aβ42, Aβ1–42% and Aβ1–40(ox)% in Alzheimer's Disease, Dementia with Lewy Bodies and Parkinson's Disease Dementia
por: Bibl, Mirko, et al.
Publicado: (2010)

Regulation of human cerebrospinal fluid malate dehydrogenase 1 in sporadic Creutzfeldt-Jakob disease patients
por: Schmitz, Matthias, et al.
Publicado: (2016)

Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer’s disease
por: Lewczuk, Piotr, et al.
Publicado: (2018)

The Subcellular Localization of an Aquaporin-2 Tetramer Depends on the Stoichiometry of Phosphorylated and Nonphosphorylated Monomers
por: Kamsteeg, E.J., et al.
Publicado: (2000)

Biomarkers for the Diagnosis of Alzheimer’s Disease in Clinical Practice: The Role of CSF Biomarkers during the Evolution of Diagnostic Criteria
por: Dulewicz, Maciej, et al.
Publicado: (2022)

Plasma YKL-40 in the spectrum of neurodegenerative dementia
por: Villar-Piqué, Anna, et al.
Publicado: (2019)

CJD mimics and chameleons
por: Mead, Simon, et al.
Publicado: (2017)

Decreased CSF Transferrin in sCJD: A Potential Pre-Mortem Diagnostic Test for Prion Disorders
por: Singh, Ajay, et al.
Publicado: (2011)

Wide distribution of prion infectivity in the peripheral tissues of vCJD and sCJD patients
por: Douet, Jean-Yves, et al.
Publicado: (2021)

High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions
por: Franceschini, Alessia, et al.
Publicado: (2017)

Nonphosphorylated tau slows down Aβ(1–42) aggregation, binds to Aβ(1–42) oligomers, and reduces Aβ(1–42) toxicity
por: Beeg, Marten, et al.
Publicado: (2021)

Tyrosine-phosphorylated and nonphosphorylated isoforms of α-dystrobrevin: roles in skeletal muscle and its neuromuscular and myotendinous junctions
por: Grady, R. Mark, et al.
Publicado: (2003)

Phosphorylated and Nonphosphorylated PfMAP2 Are Localized in the Nucleus, Dependent on the Stage of Plasmodium falciparum Asexual Maturation
por: Dahalan, Farah Aida, et al.
Publicado: (2016)

Baseline Cerebrospinal Fluid α-Synuclein in Parkinson’s Disease Is Associated with Disease Progression and Cognitive Decline
por: Emdina, Anna, et al.
Publicado: (2022)

vCJD risk in the Republic of Ireland
por: Harney, Michael S, et al.
Publicado: (2003)

Familial CJD- A Brief Commentary
por: Chandra, Satish, et al.
Publicado: (2019)

EEG Observations in Probable Sporadic CJD
por: Mundlamurri, Ravindranadh Chowdary, et al.
Publicado: (2020)

Optimization of the Real-Time Quaking-Induced Conversion Assay for Prion Disease Diagnosis
por: Zerr, Inga, et al.
Publicado: (2020)

The Various Faces of Creutzfeldt-Jakob Disease (CJD); a Case of CJD Presenting as Psychosis in a Middle-Aged Woman
por: Sodiya, Olusegun, et al.
Publicado: (2022)

A Homogenous Luminescent Proximity Assay for 14-3-3 Interactions with Both Phosphorylated and Nonphosphorylated Client Peptides
por: Du, Yuhong, et al.
Publicado: (2008)

Pseudomonas aeruginosa Nonphosphorylated AlgR Induces Ribonucleotide Reductase Expression under Oxidative Stress Infectious Conditions
por: Rubio-Canalejas, Alba, et al.
Publicado: (2023)

Epitope mapping of the protease resistant products of RT-QuIC does not allow the discrimination of sCJD subtypes
por: Piconi, Gabriele, et al.
Publicado: (2019)

Application of quantitative DTI metrics in sporadic CJD()
por: Caverzasi, E., et al.
Publicado: (2014)

Variant CJD: 18 years of research and surveillance
por: Diack, Abigail B, et al.
Publicado: (2014)

Brain microglia were activated in sporadic CJD but almost unchanged in fatal familial insomnia and G114V genetic CJD
por: Shi, Qi, et al.
Publicado: (2013)

Characteristic CSF Prion Seeding Efficiency in Humans with Prion Diseases
por: Cramm, Maria, et al.
Publicado: (2014)

Plasma Lipocalin 2 in Alzheimer’s disease: potential utility in the differential diagnosis and relationship with other biomarkers
por: Hermann, Peter, et al.
Publicado: (2022)

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
por: Lewczuk, Piotr, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qlpqobprn0ot61und648miahp9